3,246
Participants
Start Date
June 6, 2018
Primary Completion Date
October 17, 2019
Study Completion Date
October 17, 2019
VITROS Immunodiagnostic Products
NT-proBNP II assay
Montefiore Medical Center, The Bronx
Thomas Jefferson University, Philadelphia
University of Maryland (Baltimore & St. Joseph), Baltimore
INOVA Healthcare Services, Falls Church
Wake Forest University Health Sciences, Winston-Salem
Charlotte-Mecklenburg Hospital Authority (Carolinas Healthcare System), Charlotte
Drug Research Analysis Corp, Montgomery
Vanderbilt University Medical Center, Nashville
Cleveland Clinic Foundation, Cleveland
University of Cincinnati Physicians Company, Cincinnati
Indiana University Health Hospital (Eskenazi & Methodist), Indianapolis
William Beaumont Hospital (Royal Oak & Troy), Royal Oak
Wayne State University (Harper), Detroit
Henry Ford Health System, Detroit
Northwestern University, Evanston
Southern Clinical Research, Zachary
University of Texas Southwestern Medical Center, Dallas
Baylor College of Medicine (Ben Taub), Houston
Sun Research Institute, San Antonio
University of Arizona Banner - University Medical Center South Campus, Tucson
Clinical Research of South Nevada, Las Vegas
Westside Medical Associates of Los Angeles, Beverly Hills
University of California San Diego Health, San Diego
University of California Davis Health, Sacramento
Massachusetts General Hospital, Boston
Lead Sponsor
Ortho-Clinical Diagnostics, Inc.
INDUSTRY